PHAXIAM Therapeutics Competitors and Similar CompaniesClear all
PHAXIAM Therapeutics's competitors and similar companies include Polymun, Aeglea, Genentech and Livzon Pharmaceutical Group.
 PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. |  Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 2004 | Founding Date 1992 | Founding Date 2013 | Founding Date 1976 | Founding Date 1985 |
Type | Type Public | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Lyon, FR HQ Cambridge, US Princeton, US | Locations Klosterneuburg, AT HQ | Locations Austin, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 49 | Employees 80 | Employees 65117% increase | Employees 18,077 | Employees 9,067 |
Valuation ($) | Valuation ($) 52.8 m | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit €1.3m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income (€23.5m) (FY, 2023) | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Polymun
HQ
Klosterneuburg, AT
Employees
80
Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company